채혈관 시장 : 튜브 유형, 재질, 용량, 채혈 기술, 환자층, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Blood Collection Tubes Market is projected to grow by USD 7.23 billion at a CAGR of 7.33% by 2032.

Blood Collection Tubes Market Overview

Blood collection tubes are foundational consumables in clinical diagnostics, blood screening, therapeutic monitoring, clinical research, and biobanking. The blood collection tubes market is shaped by sustained demand for venous blood collection, rising use of automated laboratory analyzers, and the critical role of preanalytical quality in producing reliable test results.

Evacuated blood collection tubes, serum separator tubes, EDTA tubes, heparin tubes, citrate tubes, glucose tubes, and specialized trace element or molecular diagnostic tubes serve distinct workflows across hospitals, diagnostic laboratories, blood banks, and research institutions. Industry growth is closely linked to procedure volumes, healthcare access, infectious disease surveillance, chronic disease testing, and the expansion of preventive health screening.

Transformative Shifts in the Blood Collection Tubes Landscape

The market is moving from commodity phlebotomy supplies toward integrated, quality-driven specimen management. Laboratories increasingly prioritize tube performance, additive consistency, hemolysis reduction, fill-volume accuracy, and compatibility with high-throughput automation because preanalytical errors remain a recognized source of laboratory variability.

Regulatory expectations are also reshaping supplier strategies. Manufacturers must align with recognized standards and guidance, including ISO 6710 for single-use containers for venous blood specimen collection, CLSI guidance for specimen handling, FDA quality system requirements in the United States, and the EU In Vitro Diagnostic Regulation for relevant diagnostic-use products. Sustainability is becoming a procurement factor as healthcare systems evaluate plastic use, sterilization processes, packaging, transport efficiency, and supply resilience.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the blood collection tubes ecosystem by improving demand planning, inventory visibility, defect detection, and laboratory workflow optimization. AI-enabled analytics can help hospitals and laboratories anticipate tube consumption by test mix, seasonality, emergency department activity, and outreach testing volumes, reducing both stockouts and excess inventory.

In manufacturing, machine vision and statistical process control support inspection of caps, labels, vacuum integrity, fill indicators, and packaging defects. In laboratories, AI-driven systems can flag hemolysis, clotting risk, underfilled tubes, labeling discrepancies, and transport delays when integrated with laboratory information systems and automated analyzers. These applications do not replace validated clinical procedures, but they strengthen traceability, quality assurance, and operational efficiency.

Key Regional Insights for Blood Collection Tubes

Asia-Pacific is a high-priority region for blood collection tubes due to expanding diagnostic infrastructure, hospital investments, aging populations in markets such as Japan, South Korea, and China, and large-volume testing demand in India and Southeast Asia. Local manufacturing capacity, public health screening programs, and private laboratory networks are strengthening regional supply availability while increasing competition across standard evacuated tubes and premium specialty tubes.

North America remains a mature and innovation-led region, supported by advanced clinical laboratory networks, high automation adoption, stringent quality expectations, and broad use of routine and specialized blood testing. Europe emphasizes compliance, product traceability, and sustainability under rigorous regulatory frameworks, including evolving requirements for diagnostic-use products. Latin America shows demand momentum tied to healthcare access expansion, infectious disease testing, chronic disease monitoring, and private diagnostics. The Middle East is investing in hospital modernization, laboratory accreditation, and centralized procurement, while Africa presents long-term opportunity as diagnostic access, blood safety programs, and public health laboratory capacity continue to develop.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are benefiting from expanding healthcare coverage, medical tourism, and investment in diagnostic laboratories across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. Demand is broadening from standard serum and EDTA tubes toward higher-quality evacuated blood collection systems that support automation, reduce specimen rejection, and improve preanalytical consistency.

The GCC is characterized by strong hospital investment, centralized procurement, and growing demand for internationally compliant laboratory supplies. The European Union prioritizes regulatory conformity, environmental performance, and cross-border quality expectations under the IVDR environment. BRICS countries combine large patient populations with expanding domestic manufacturing and public health testing demand. G7 markets lead in automation, quality systems, accreditation-driven procurement, and premium tube adoption, while NATO member countries place additional emphasis on supply security, emergency preparedness, and resilient medical logistics.

Key Country Insights in Major Blood Collection Tube Markets

The United States leads in advanced diagnostic testing, laboratory automation, and stringent product quality expectations, while Canada benefits from standardized healthcare procurement and strong laboratory accreditation practices. Mexico and Brazil are important demand centers in Latin America, supported by private diagnostics growth, hospital modernization, and public health testing needs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain represent established markets with high clinical testing volumes, quality-focused procurement, and adoption of automated laboratory workflows, while Germany is especially important for laboratory technology and manufacturing excellence. Russia maintains demand through hospital and public-sector testing despite procurement complexity. China and India are major growth engines due to scale, domestic production, and expanding diagnostics access. Japan, Australia, and South Korea are quality-focused markets with strong automation, aging-population testing needs, and advanced clinical laboratory infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize product quality, regulatory readiness, and supply chain resilience. Investments in validated additive systems, vacuum stability, tube-label durability, sterilization controls, closure integrity, and compatibility with automated analyzers can differentiate suppliers in hospital and reference laboratory procurement.

Manufacturers and distributors should expand regional manufacturing, dual-sourcing strategies, and inventory visibility to reduce disruption risk. Commercial teams should align portfolios with local testing needs, including serum separator tubes for chemistry, EDTA tubes for hematology, citrate tubes for coagulation, heparin tubes for plasma testing, glucose tubes for metabolic testing, and specialty tubes for molecular diagnostics, trace elements, and blood stabilization. Sustainability claims should be supported by measurable packaging, materials, transport, and lifecycle improvements.

Research Methodology

This executive summary is based on secondary research and market intelligence synthesis from publicly available and verifiable sources, including regulatory guidance, standards bodies, healthcare procurement patterns, national health statistics, trade data, public health documentation, and laboratory medicine best practices. Key reference frameworks include ISO 6710, CLSI specimen collection and handling guidance, FDA medical device oversight, and the European IVDR environment.

The analysis applies triangulation across demand indicators such as diagnostic testing utilization, healthcare infrastructure development, laboratory automation adoption, population health trends, public screening activity, and regional manufacturing activity. Qualitative validation focuses on product segmentation, end-user procurement behavior, supply chain dynamics, quality expectations, and regulatory requirements affecting blood collection tubes and related phlebotomy consumables.

Conclusion

The blood collection tubes market is advancing from a volume-based consumables category into a quality-critical segment of the diagnostic value chain. Reliable specimen collection directly affects test accuracy, turnaround time, patient safety, and laboratory productivity, making tube selection a strategic procurement decision for healthcare providers.

Future competitiveness will depend on manufacturing precision, regulatory compliance, automation compatibility, resilient supply networks, and evidence-backed product performance. Suppliers that combine dependable evacuated blood collection systems with digital quality tools, regional responsiveness, and sustainable operations will be best positioned to capture long-term demand without compromising specimen integrity or clinical reliability.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blood Collection Tubes Market, by Tube Type

• 7.1. Citrate Tubes
• 7.2. EDTA Tubes
• 7.3. Glucose Tubes
• 7.4. Heparin Tubes
• 7.5. Plasma Separation Tubes (PST)
• 7.6. Serum Separation Tubes (SST)

8. Blood Collection Tubes Market, by Material

• 8.1. Glass Tubes
• 8.2. Plastic Tubes

9. Blood Collection Tubes Market, by Volume Capacity

• 9.1. Low-Volume Tubes
• 9.2. Standard-Volume Tubes
• 9.3. High-Volume Tubes

10. Blood Collection Tubes Market, by Collection Technology

• 10.1. Evacuated Tubes
• 10.2. Non-Evacuated Tubes
• 10.3. Microcollection Tubes

11. Blood Collection Tubes Market, by Patient Group

• 11.1. Adult
• 11.2. Pediatric
• 11.3. Neonatal
• 11.4. Geriatric

12. Blood Collection Tubes Market, by Application

• 12.1. Blood Banking
• 12.2. Clinical Diagnostics
• 12.3. Forensic
• 12.4. Molecular Diagnostics
• 12.5. Research & Development

13. Blood Collection Tubes Market, by End User

• 13.1. Hospitals & Clinics
• 13.2. Diagnostic Laboratories
• 13.3. Blood Collection Centers
• 13.4. Ambulatory Surgical Centers

14. Blood Collection Tubes Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Blood Collection Tubes Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Blood Collection Tubes Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Abbott Laboratories
• 18.2. AdvaCare Pharma
• 18.3. Becton, Dickinson & Company
• 18.4. Biosigma S.p.A.
• 18.5. Bio-Rad Laboratories, Inc.
• 18.6. Cardinal Health, Inc.
• 18.7. CML BIOTECH LIMITED
• 18.8. Convergent Technologies GmbH
• 18.9. Corning Incorporated
• 18.10. FL Medical S.R.L.
• 18.11. Greiner Bio One International Gmbh
• 18.12. Haemonetics Corporation
• 18.13. Labtech S.r.l.
• 18.14. Medline Industries, Inc.
• 18.15. Medtronic plc
• 18.16. Merck KGaA
• 18.17. Micsafe Medical Group
• 18.18. Nanjing Vazyme Medical Technology Co., Ltd.
• 18.19. Nipro Medical Corporation
• 18.20. QIAGEN N.V.
• 18.21. Radiometer Medical ApS
• 18.22. SARSTEDT AG & Co. KG
• 18.23. Simport, Inc.
• 18.24. Terumo Corporation
• 18.25. Thermo Fisher Scientific Inc.